spacer
home > ebr > summer 2003 > maximising return on investment with r&d portfolio management
PUBLICATIONS
European Biopharmaceutical Review

Maximising Return on Investment with R&D Portfolio Management

Product prioritisation at a tactical level - identifying the most desirable and attractive products in a company's R&D pipeline - remains the primary focus of portfolio management today. This factor, coupled with the need to maximise return on investment, acts as a strong driving force for pharmaceutical companies to perform portfolio management.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Morten Soegaard, Research Analyst at Frost & Sullivan


Morten Soegaard, a Research Analyst at Frost & Sullivan, has recently finished his analysis on R&D Portfolio Management. As a member of the pharmaceuticals team he previously investigated the European market on commercial opportunities for inhalation drug delivery in diabetes.

spacer
Morten Soegaard
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Group Industry Awards 2019

PPMA Group is today issuing a ‘Final Call for Entries’ to the 2019 PPMA Group Industry Awards. All companies within the packaging and processing sector are invited to submit their FREE submission by the deadline of 17 July 2019.
More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

 
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement